Rtw-Investments-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AKRO",
  "AXSM",
  "CNTA",
  "ALKS",
  "INSM",
  "TEM",
  "ARGX",
  "RDNT",
  "ACAD",
  "MASI",
  "CBLL",
  "MDGL",
  "PTCT",
  null,
  "RCKT",
  "ARVN",
  "IMTX",
  "TSHA",
  "LENZ",
  "STOK",
  "REPL",
  "ADGM",
  "NGNE",
  null,
  "BIOA",
  null,
  "ESTA",
  "SYRE",
  "APGE",
  "ISRG",
  "TARS",
  "MIST",
  "GHRS",
  "GEHC",
  null,
  "DGX",
  null,
  "SYK",
  "RAPT",
  "PTGX",
  "RNA",
  "TENX",
  "QURE",
  "ETNB",
  "DYN",
  "GKOS",
  "GMED",
  "PEN",
  "NTRA",
  "WVE",
  "CMPS",
  "CRVS",
  "XGN",
  "IMCR",
  "URGN",
  "VRNA",
  "VSTM",
  "ZLAB",
  "OBIO",
  "XNCR",
  "ORKA",
  "RARE",
  "BEAM",
  "CRGX",
  "CGON",
  "CGEM",
  "CYTK"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 68
Total Value: 6538371722
Accession Number: 0001493215-25-000003
Form Type: 13F-HR
CIK: rtw-investments-lp
Manager Name: Rtw-Investments-Lp

Data Enrichment

93% identified

63 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

68 positions • $6.5B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 4

Sort by:

ARVINAS, INC.

ARVN|04335A105

Shares:3.3M

Value:$23.4M

% of Portfolio:0.4% ($23.4M/$6.5B)

LENZ Therapeutics, Inc.

LENZ|52635N103

Shares:863.4K

Value:$22.2M

% of Portfolio:0.3% ($22.2M/$6.5B)

Replimune Group, Inc.

REPL|76029N106

Shares:2.1M

Value:$20.1M

% of Portfolio:0.3% ($20.1M/$6.5B)

Oruka Therapeutics, Inc.

ORKA|687604108

Shares:1.9M

Value:$20.0M

% of Portfolio:0.3% ($20.0M/$6.5B)

Tempus AI, Inc.

TEM|88023B103

Shares:400.0K

Value:$19.3M

% of Portfolio:0.3% ($19.3M/$6.5B)

GLAUKOS Corp

GKOS|377322102

Shares:190.0K

Value:$18.7M

% of Portfolio:0.3% ($18.7M/$6.5B)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:1.7M

Value:$17.7M

% of Portfolio:0.3% ($17.7M/$6.5B)

CARGO Therapeutics, Inc.

CRGX|14179K101

Shares:4.1M

Value:$16.8M

% of Portfolio:0.3% ($16.8M/$6.5B)

QUEST DIAGNOSTICS INC

DGX|74834L100

Shares:99.0K

Value:$16.8M

% of Portfolio:0.3% ($16.8M/$6.5B)

COMPASS Pathways plc

CMPS|20451W101

Shares:5.5M

Value:$15.8M

% of Portfolio:0.2% ($15.8M/$6.5B)

Neurogene Inc.

NGNE|64135M105

Shares:1.3M

Value:$15.8M

% of Portfolio:0.2% ($15.8M/$6.5B)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:11.8M

Value:$14.4M

% of Portfolio:0.2% ($14.4M/$6.5B)

89bio, Inc.

ETNB|282559103

Shares:2.0M

Value:$14.3M

% of Portfolio:0.2% ($14.3M/$6.5B)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:1.7M

Value:$12.9M

% of Portfolio:0.2% ($12.9M/$6.5B)

Beam Therapeutics Inc.

BEAM|07373V105

Shares:438.7K

Value:$8.6M

% of Portfolio:0.1% ($8.6M/$6.5B)

Corvus Pharmaceuticals, Inc.

CRVS|221015100

Shares:2.7M

Value:$8.5M

% of Portfolio:0.1% ($8.5M/$6.5B)

G70077105

Shares:742.5K

Value:$7.6M

% of Portfolio:0.1% ($7.6M/$6.5B)

Wave Life Sciences Ltd.

WVE|Y95308105

Shares:900.0K

Value:$7.3M

% of Portfolio:0.1% ($7.3M/$6.5B)

EXAGEN INC.

XGN|30068X103

Shares:1.5M

Value:$5.4M

% of Portfolio:0.1% ($5.4M/$6.5B)

G52441105

Shares:200.0K

Value:$5.0M

% of Portfolio:0.1% ($5.0M/$6.5B)

Instrument	Shares		Other Manager	Value	% of Portfolio
ARVINAS, INC.(ARVNcusip04335A105)	3.3M	QoQ 0.00% (-0) YoY +1.10% (-36.4K)	All Managers (Combined)	$23.4M	0.4% ($23.4M/$6.5B)	QoQ -63.38% (-$40.5M) YoY -82.80% (-$112.7M)
LENZ Therapeutics, Inc.(LENZcusip52635N103)	863.4K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$22.2M	0.3% ($22.2M/$6.5B)	QoQ -10.94% (-$2.7M) YoY +15.13% (+$2.9M)
Replimune Group, Inc.(REPLcusip76029N106)	2.1M	QoQ 0.00% (-0) YoY NEW(+2.1M)	All Managers (Combined)	$20.1M	0.3% ($20.1M/$6.5B)	QoQ -19.48% (-$4.9M) YoY NEW(+$20.1M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	1.9M	QoQ 0.00% (-0) YoY NEW(+1.9M)	All Managers (Combined)	$20.0M	0.3% ($20.0M/$6.5B)	QoQ -47.08% (-$17.8M) YoY NEW(+$20.0M)
Tempus AI, Inc.(TEMcusip88023B103)	400.0K	QoQ NEW(+400.0K) YoY NEW(+400.0K)	All Managers (Combined)	$19.3M	0.3% ($19.3M/$6.5B)	QoQ NEW(+$19.3M) YoY NEW(+$19.3M)
GLAUKOS Corp(GKOScusip377322102)	190.0K	QoQ NEW(+190.0K) YoY +223.17% (+131.2K)	All Managers (Combined)	$18.7M	0.3% ($18.7M/$6.5B)	QoQ NEW(+$18.7M) YoY +237.33% (+$13.2M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	1.7M	QoQ -67.60% (-3.5M) YoY -45.31% (-1.4M)	All Managers (Combined)	$17.7M	0.3% ($17.7M/$6.5B)	QoQ -85.61% (-$105.3M) YoY -79.85% (-$70.1M)
CARGO Therapeutics, Inc.(CRGXcusip14179K101)	4.1M	QoQ 0.00% (-0) YoY +10.41% (-389.2K)	All Managers (Combined)	$16.8M	0.3% ($16.8M/$6.5B)	QoQ -71.77% (-$42.7M) YoY -79.86% (-$66.6M)
QUEST DIAGNOSTICS INC(DGXcusip74834L100)	99.0K	QoQ NEW(+99.0K) YoY NEW(+99.0K)	All Managers (Combined)	$16.8M	0.3% ($16.8M/$6.5B)	QoQ NEW(+$16.8M) YoY NEW(+$16.8M)
COMPASS Pathways plc(CMPScusip20451W101)	5.5M	QoQ +78.70% (+2.4M) YoY NEW(+5.5M)	All Managers (Combined)	$15.8M	0.2% ($15.8M/$6.5B)	QoQ +35.21% (+$4.1M) YoY NEW(+$15.8M)
Neurogene Inc.(NGNEcusip64135M105)	1.3M	QoQ -0.11% (-1.6K) YoY +75.35% (-579.5K)	All Managers (Combined)	$15.8M	0.2% ($15.8M/$6.5B)	QoQ -48.83% (-$15.1M) YoY -59.65% (-$23.4M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	11.8M	QoQ 0.00% (-0) YoY NEW(+11.8M)	All Managers (Combined)	$14.4M	0.2% ($14.4M/$6.5B)	QoQ -22.78% (-$4.2M) YoY NEW(+$14.4M)
89bio, Inc.(ETNBcusip282559103)	2.0M	QoQ -73.68% (-5.5M) YoY -73.33% (-5.4M)	All Managers (Combined)	$14.3M	0.2% ($14.3M/$6.5B)	QoQ -75.53% (-$44.2M) YoY -83.34% (-$71.6M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	1.7M	QoQ 0.00% (-0) YoY NEW(+1.7M)	All Managers (Combined)	$12.9M	0.2% ($12.9M/$6.5B)	QoQ -37.84% (-$7.9M) YoY NEW(+$12.9M)
Beam Therapeutics Inc.(BEAMcusip07373V105)	438.7K	QoQ NEW(+438.7K) YoY NEW(+438.7K)	All Managers (Combined)	$8.6M	0.1% ($8.6M/$6.5B)	QoQ NEW(+$8.6M) YoY NEW(+$8.6M)
Corvus Pharmaceuticals, Inc.(CRVScusip221015100)	2.7M	QoQ 0.00% (-0) YoY NEW(+2.7M)	All Managers (Combined)	$8.5M	0.1% ($8.5M/$6.5B)	QoQ -40.56% (-$5.8M) YoY NEW(+$8.5M)
(cusipG70077105)✕	742.5K	QoQ 0.00% (+0) YoY NEW(+742.5K)	All Managers (Combined)	$7.6M	0.1% ($7.6M/$6.5B)	QoQ +1.17% (+$89.1K) YoY NEW(+$7.6M)
Wave Life Sciences Ltd.(WVEcusipY95308105)	900.0K	QoQ 0.00% (-0) YoY NEW(+900.0K)	All Managers (Combined)	$7.3M	0.1% ($7.3M/$6.5B)	QoQ -34.68% (-$3.9M) YoY NEW(+$7.3M)
EXAGEN INC.(XGNcusip30068X103)	1.5M	QoQ 0.00% (-0) YoY +0.48% (+7.3K)	All Managers (Combined)	$5.4M	0.1% ($5.4M/$6.5B)	QoQ -12.43% (-$771.1K) YoY +126.87% (+$3.0M)
(cusipG52441105)✕	200.0K	QoQ NEW(+200.0K) YoY NEW(+200.0K)	All Managers (Combined)	$5.0M	0.1% ($5.0M/$6.5B)	QoQ NEW(+$5.0M) YoY NEW(+$5.0M)